title: The Sunshine Act and Transfers of Value: Impact on Non-industry Authorship.
abstract: The United States Physician Payments Sunshine Act requires pharmaceutical and device manufacturers that participate in United States federal healthcare programs to report certain payments and items of value given to physicians and teaching hospitals. One of these "transfers of value" is the cost of expediting the preparation and publication of industry-sponsored journal articles with the use of outside editorial assistance. This can be problematic for those United Statesbased physician-authors whose home institutions have implemented policies to distance their faculty from pharmaceutical and device manufacturers. Potential strategies include using in-house editorial assistance when available, but transfers of value remain subject to further interpretation, and company policies are not uniform industrywide.
authors.affiliation: Dr. Citrome is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College in Valhalla, New York, and is the Editor-in-Chief for the International Journal of Clinical Practice, published by Wiley-Blackwell. He is also a member of the World Association of Medical Editors, the International Society for Medical Publication Professionals, and a participant in the Medical Publishing Insights and Practices initiative.
authors.forename: Leslie
authors.initials: L
authors.lastname: Citrome
keywords: Acknowledgments; Sunshine Act; authorship; disclosure; pharmaceutical and device manufacturers; transfers of value